Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of May 2026
Daisy Harvey @Daisy Harvey
Platinum member since January 2017

Location: United States

Gender: Female

Asset investment style: Quantitative fundamental analysis

Market capitalization:

$8,000,279talents

Virtual portfolio value:

$4,966,579talents

Net overall return per annum:

18.69%

AYA current rank order:

#16

Asset investment philosophy:
Daisy Harvey trades U.S. stocks with the top #76 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
VATE INNOVATE Corp. Common Stock $0.53 $4.14 56,283 +681.13% $203,182
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 24,133 +2,108.33% $183,169
LGVN Longeveron Inc. Class A Common Stock $3.45 $26.25 2,347 +660.87% $53,512
AXSM Axsome Therapeutics Inc. Common Stock $4.60 $31.75 1,335 +590.22% $36,245
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 881 +589.24% $36,183
SQ Block Inc. Class A Common Stock $14.50 $99.54 423 +586.48% $35,972
FIVN Five9 Inc. Common Stock $16.31 $110.10 376 +575.05% $35,265
TRNS Transcat Inc. Common Stock $11.35 $73.00 541 +543.17% $33,353
GLOB Globant S.A. Common Shares $34.57 $215.99 177 +524.79% $32,111
HZNP Horizon Therapeutics Public Limited Company Ordinary Shares $16.41 $98.56 374 +500.61% $30,724
Sum $679,716

Top 10 current stock portfolio positions as of May 2026Strategy

Symbol Company Price Position Capitalization
DGXX Digi Power X Inc. Subordinate Voting Shares $6.63 5,470 $36,266
LICN Lichen International Limited Class A Ordinary Shares $6.88 4,431 $30,485
AAON AAON Inc. Common Stock $139.66 197 $27,513
STKE Sol Strategies Inc. Common Shares $1.83 14,868 $27,208
SITM SiTime Corporation Common Stock $833.08 32 $26,658
APT Alpha Pro Tech Ltd. Common Stock $6.44 4,008 $25,811
QURE uniQure N.V. Ordinary Shares $27.66 924 $25,557
NVCT Nuvectis Pharma Inc. Common Stock $11.65 2,153 $25,082
MBX MBX Biosciences Inc. Common Stock $40.97 610 $24,991
NAMS NewAmsterdam Pharma Company N.V. Ordinary Shares $38.73 645 $24,980
Sum $274,551

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@Chanel Holden
@Andy Yeh Alpha

Blog+More

President Trump meets Chinese President Xi for better economic reforms.

Rose Prince

2017-03-21 09:37:00 Tuesday ET

President Trump meets Chinese President Xi for better economic reforms.

Trump and Xi meet in the most important summit on earth this year. Trump has promised to retaliate against China's currency misalignment, steel trade

+See More

Volcker, Greenspan, Bernanke, and Yellen contribute to a Wall Street Journal op-ed on monetary policy independence.

Olivia London

2019-09-23 12:25:00 Monday ET

Volcker, Greenspan, Bernanke, and Yellen contribute to a Wall Street Journal op-ed on monetary policy independence.

Volcker, Greenspan, Bernanke, and Yellen contribute to a Wall Street Journal op-ed on monetary policy independence. These former Federal Reserve chiefs unit

+See More

Ray Fair applies his macroeconometric model to study the central features of the U.S. macroeconomy such as price stability and full employment in the dual mandate.

Charlene Vos

2023-07-14 10:32:00 Friday ET

Ray Fair applies his macroeconometric model to study the central features of the U.S. macroeconomy such as price stability and full employment in the dual mandate.

Ray Fair applies his macroeconometric model to study the central features of the U.S. macroeconomy such as price stability and full employment in the dual m

+See More

It may be illegal for institutional investors to buy-and-hold large equity stakes in a less competitive industry with high market concentration.

Olivia London

2017-11-27 07:39:00 Monday ET

It may be illegal for institutional investors to buy-and-hold large equity stakes in a less competitive industry with high market concentration.

Is it anti-competitive and illegal for passive indexers and mutual funds to place large stock bets in specific industries with high market concentration? Ha

+See More

Apple revises down its global sales revenue estimate to $83 billion due to subpar smartphone sales in China.

James Campbell

2019-01-09 07:33:00 Wednesday ET

Apple revises down its global sales revenue estimate to $83 billion due to subpar smartphone sales in China.

Apple revises down its global sales revenue estimate to $83 billion due to subpar smartphone sales in China. Apple CEO Tim Cook points out the fact that he

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More